Insights

Paediatric Inflammatory Multisystem Syndrome (PIMS) is a rare but serious complication of COVID-19 in children. This report details the first critically ill pediatric PIMS cases in the Czech Republic.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Rheumatology

Background:

  • COVID-19 predominantly causes mild illness in children.
  • A subset of pediatric COVID-19 cases can develop Paediatric Inflammatory Multisystem Syndrome (PIMS).
  • PIMS presents with diverse symptoms including fever, gastrointestinal issues, neurological signs, and multiorgan dysfunction.

Purpose of the Study:

  • To report the initial cases of critically ill pediatric patients with PIMS in the Czech Republic.
  • To highlight the clinical presentation and severity of PIMS in a pediatric population.

Main Methods:

  • Case series reporting on three critically ill pediatric patients.
  • Clinical data collection including symptoms, disease course, and management.

Main Results:

  • Three pediatric patients presented with severe PIMS following SARS-CoV-2 infection.
  • Patients exhibited symptoms such as high fever, gastrointestinal distress, neurological involvement, and multiorgan dysfunction.
  • These represent the first documented critically ill pediatric PIMS cases in the Czech Republic.

Conclusions:

  • PIMS is a significant, albeit rare, complication of COVID-19 in children requiring intensive care.
  • Early recognition and management are crucial for pediatric patients with severe PIMS.
  • This report underscores the importance of monitoring for PIMS in pediatric COVID-19 cases.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
669
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
904
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17